STRGX
Price
$67.07
Change
-$0.55 (-0.81%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

STRGX vs VIMSX

Header iconSTRGX vs VIMSX Comparison
Open Charts STRGX vs VIMSXBanner chart's image
Sterling Capital MdCp Relatv Val Instl
Price$67.07
Change-$0.55 (-0.81%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
STRGX vs VIMSX Comparison Chart
Loading...
VS
STRGX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STRGX is a StrongBuy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. STRGX (40.8M). VIMSX pays higher dividends than STRGX: VIMSX (1.38) vs STRGX (0.68). STRGX was incepted earlier than VIMSX: STRGX (52 years) vs VIMSX (26 years). VIMSX is a more actively managed with annual turnover of: 13.00 vs. STRGX (4.89). VIMSX has a lower initial minimum investment than STRGX: VIMSX (3000) vs STRGX (1000000). VIMSX annual gain was more profitable for investors over the last year : 25.11 vs. STRGX (9.15). VIMSX return over 5 years is better than : 56.75 vs. STRGX (7.92).
STRGXVIMSXSTRGX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence52 years26 years-
Gain YTD11.06112.55788%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets40.8M172B0%
Annual Yield % from dividends0.681.3849%
Returns for 1 year9.1525.1136%
Returns for 3 years-11.959.82-122%
Returns for 5 years7.9256.7514%
Returns for 10 years29.99128.2123%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma